Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David N. Gill currently holds 86,887 shares of Strongbridge Biopharma plc (SBBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David N. Gill has been a net seller of SBBP stock. They have purchased $210.5K and sold $633.3K worth of shares.
David N. Gill's most recent insider trade was on Feb 17, 2026, when they sold 45,559 shares at $0.00 per share.
David N. Gill serves as Executive at Strongbridge Biopharma plc (SBBP). They have executed 52 insider transactions totaling $843.7K over their tenure at the company.
David N. Gill holds the position of Executive at Strongbridge Biopharma plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
David N. Gill has shown a selling trading pattern, with $210.5K in total purchases and $633.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David N. Gill was on Nov 22, 2016, when they sold $1.0M worth of GI shares. This transaction involved 125,445 shares at $8.00 per share.
David N. Gill currently owns 86,887 shares of Strongbridge Biopharma plc (SBBP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David N. Gill's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David N. Gill has 52 Form 4 filings on record as an insider at Strongbridge Biopharma plc.
Set alerts for David N. Gill and 40,000+ other insiders.